Oliver’s Law: Campaign Calls for Changes to Medical Cannabis Prescribing in Psychiatric Conditions
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
24 results for “liver”
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
Cannabinoids were shown to reduce toxicity in the liver caused by ethanol.
Dispenseroo sells high-THC cannabis products online
Oral administration of cannabidiol by humans typically results in bioavailability levels of 6.5-20 per cent.
From kiosks to mountain top vending machines: CBD brands are getting creative for 2022
Previous studies have shown conflicting results leading to confusion about how it may affect the liver
A first-of-its-kind study has found no evidence of liver toxicity in more than 800 adults consuming CBD. Following seven months of clinical investigation, researchers have reported no preliminary evidence of […]
Dragonfly Biosciences is expanding its CBD extraction capability, to enable the large scale delivery of over 1,000kg of CBD per month. The manufacturers of Dragonfly CBD oil has acquired full […]
The Irish government’s move to ensure patients have access to medical cannabis has been tentatively welcomed by campaigners. Following repeated calls from campaigners, Ireland’s Government announced that an arrangement to […]
A new free delivery service in Los Angeles is bringing high quality, legal cannabis products to customers on demand. The new cannabis delivery service in the Los Angeles area last […]
Home deliveries of medicinal cannabis have been made available to patients seeking private access to the treatment while avoiding the threat of COVID-19.
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.